Search research articles
Contact Us
Filters
Showing results (141-150 of 148) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 148 results.
Leukemia
|
April 9, 2004
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)
C-M Wendtner, M Ritgen, C D Schweighofer, et al.
Leukemia Research
|
January 1, 1982
Multicentre study on intensified remission induction therapy for acute myeloid leukemia
T Büchner, D Urbanitz, B Emmerich, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 30, 2017
Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer
Chelsea Hope, Philip B Emmerich, Athanasios Papadas, et al.
Cancers
|
May 14, 2025
Stromal Versican Accumulation and Proteolysis Regulate the Infiltration of CD8<sup>+</sup> T Cells in Breast Cancer
Philip B Emmerich, Tonela Qyli, Katherine A Johnson, et al.
Journal of Surgical Oncology
|
January 6, 2025
Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer
Nataliya V Uboha, Mustafa M Basree, Jens C Eickhoff, et al.
British Journal of Haematology
|
September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group
M Hallek, B Schmitt, M Wilhelm, et al.
Leukemia
|
August 15, 2017
Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group
M A Hoechstetter, R Busch, B Eichhorst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2019
Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation
Cheri A Pasch, Peter F Favreau, Alexander E Yueh, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 148) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 148 results.
Leukemia
|
April 9, 2004
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)
C-M Wendtner, M Ritgen, C D Schweighofer, et al.
Leukemia Research
|
January 1, 1982
Multicentre study on intensified remission induction therapy for acute myeloid leukemia
T Büchner, D Urbanitz, B Emmerich, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 30, 2017
Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer
Chelsea Hope, Philip B Emmerich, Athanasios Papadas, et al.
Cancers
|
May 14, 2025
Stromal Versican Accumulation and Proteolysis Regulate the Infiltration of CD8<sup>+</sup> T Cells in Breast Cancer
Philip B Emmerich, Tonela Qyli, Katherine A Johnson, et al.
Journal of Surgical Oncology
|
January 6, 2025
Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer
Nataliya V Uboha, Mustafa M Basree, Jens C Eickhoff, et al.
British Journal of Haematology
|
September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group
M Hallek, B Schmitt, M Wilhelm, et al.
Leukemia
|
August 15, 2017
Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group
M A Hoechstetter, R Busch, B Eichhorst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2019
Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation
Cheri A Pasch, Peter F Favreau, Alexander E Yueh, et al.
Page
of 15